Living with psoriasis: prevalence of shame, anger, worry, and problems in daily activities and social life.
about
A multicenter, non-interventional study to evaluate patient-reported experiences of living with psoriasis.The psychosocial impact of acne, vitiligo, and psoriasis: a reviewHealth-related quality of life worsens disproportionately to objective signs of psoriasis after withdrawal of adalimumab therapy.Itch, disease coping strategies and quality of life in psoriasis patients.How do disease perception, treatment features, and dermatologist-patient relationship impact on patients assuming topical treatment? An Italian survey.Development and psychometric validation of the REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire: a common measure of plaque-type psoriasis severity and treatment efficacy for patients and clinicians.Oral Chinese herbal medicine combined with pharmacotherapy for psoriasis vulgaris: a systematic review.Influence of Psoriasis on Household Chores and Time Spent on Skin Care at Home: A Questionnaire Study.Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan.Psoriasis Patients' Knowledge about the Disease and Treatments.Prevalence of psoriasis phenotypes among men and women in the USA.Psychopathological Variables and Sleep Quality in Psoriatic PatientsThe Lived Experience of Psoriasis Patients from Social Stigma and Rejection: A Qualitative Study.Optimism as a predictor of health-related quality of life in psoriatics.Patient-reported outcome measures in psoriasis: the good, the bad and the missing!Psoriasis and psycho-dermatology.Barriers to guideline-compliant psoriasis care: analyses and concepts.Education to improve quality of life of people with chronic inflammatory skin conditions: a systematic review of the evidence.Health-related quality of life in patients with psoriasis: a systematic review of the European literature.Rapid improvements in health-related quality of life and itch with ixekizumab treatment in randomized phase 3 trials: results from UNCOVER-2 and UNCOVER-3.Psoriasis: snapshots of the unspoken: using novel methods to explore patients' personal models of psoriasis and the impact on well-being.Disease-induced level of shame in patients with acne, psoriasis and syphilis.Mental health among people with psoriasis undergoing patient education in climate therapy.Social problem-solving, perceived stress, negative life events, depression and life satisfaction in psoriasis.The impact of psoriasis on work-related problems: a multicenter cross-sectional survey.Cost-Effectiveness Analysis of Ixekizumab vs Etanercept and Their Manufacturer-Recommended Dosing Regimens in Moderate to Severe Plaque Psoriasis.Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis.Measurement properties of a patient-reported outcome measure assessing psoriasis severity: The psoriasis symptoms and signs diary.Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary.Identification of psoriatic patients at risk of high quality of life impairment.The relative impact of psoriasis and obesity on socioeconomic and medical outcomes in psoriasis patients.9-cis-rich β-carotene powder of the alga Dunaliella reduces the severity of chronic plaque psoriasis: a randomized, double-blind, placebo-controlled clinical trial.Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition.Randomized, controlled study of bleselumab (ASKP1240) pharmacokinetics and safety in patients with moderate-to-severe plaque psoriasis.The impact of genital psoriasis on quality of life: a systematic review
P2860
Q27334725-8CE50EBC-FA0B-43A0-ABDF-15A141BB8287Q28066163-9C4AE86D-56F6-4C13-A239-BE56149476FFQ33785083-CAC3B4D0-580D-48D8-B025-436945E63955Q34457913-2F28F1A9-2079-4BF4-9D21-3E53F4810F47Q35111430-EB7A87A6-189C-4462-8265-46169D66B1CAQ35175365-F493E0A2-06A0-40E2-A891-31CAD503AFA9Q35246473-75EE4EDE-61F2-493A-AD5D-2F29694C7912Q35752518-B3C5AB8F-1ADB-45DC-B70E-C8204A30C173Q36083240-56E89491-4B0E-468C-8E2F-2CC1D032F58FQ36999519-575C74B2-19D7-46E0-8957-91A4E3A71534Q37026460-AA04400B-3BAB-491D-89F1-931669695876Q37134741-0E8D4B62-7346-49EC-B8B2-686AC5D3601BQ37262823-97D37E23-6D70-49D9-AC4D-46CB21BCBCEEQ37327130-B32B0A66-51FF-4EFA-98F2-59E9BD350141Q38354062-847D6CFA-CBA0-4716-A53D-ABCBEAD0BD60Q38443811-BA0CBCEF-D802-46E6-BEC1-1EDEA7B147BBQ38625686-2E19AFEB-7143-4AF4-8334-F0EF9D1E5C87Q38718781-9228D363-F1F3-4EE0-A3B2-3A9443CDF111Q38853236-A6E563F3-BD17-4CB5-B5E6-C1C011F1F6DBQ38907492-8A10D0F2-A55F-4A0F-B05A-59422ED26258Q39195245-873AEB2B-BA25-4C09-B4FD-40E59BBCBECDQ42239155-A6874676-FDA8-4CEA-B396-66B7A6E7579FQ46084816-6F6E5093-8D38-41BE-8D82-78CF78181D43Q46818451-B39A01D0-DC4D-4591-9AD4-F3C611FBA625Q46840956-1DAC08BD-7407-421F-BA7E-A36EA32A5B8FQ47647524-57387551-ED2E-4313-AC09-13858CB34251Q47862404-2D1E3355-1666-4B87-AB46-FD7454A17682Q47892380-6C817A8E-EAD3-414D-B853-577E91F6B750Q48076347-9A13C0BE-226F-467C-9CBC-A057949FC0EDQ48184749-D9032A97-6558-4B49-8EFB-2ADAAC0CCB35Q48198816-CFAD012D-2C30-42B5-BEDE-AC6E03D599DEQ48271832-1F20D32E-CA9F-439B-9184-BB15ACF7D4A3Q53828883-1AF26BD1-8A26-4CF0-A2D7-DBB9E1FAA7A1Q55552584-6D02E56A-0DD1-4E3B-8929-7C87BF366C69Q58698647-5D793101-90EE-4C46-8271-34BFD5CBAD77
P2860
Living with psoriasis: prevalence of shame, anger, worry, and problems in daily activities and social life.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Living with psoriasis: prevale ...... ly activities and social life.
@en
Living with psoriasis: prevale ...... ly activities and social life.
@nl
type
label
Living with psoriasis: prevale ...... ly activities and social life.
@en
Living with psoriasis: prevale ...... ly activities and social life.
@nl
prefLabel
Living with psoriasis: prevale ...... ly activities and social life.
@en
Living with psoriasis: prevale ...... ly activities and social life.
@nl
P2093
P356
P1476
Living with psoriasis: prevale ...... ly activities and social life.
@en
P2093
Francesca Sampogna
IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) investigators
Stefano Tabolli
P304
P356
10.2340/00015555-1273
P577
2012-05-01T00:00:00Z